What is Pacira BioSciences, Inc.'s raw materials?

Pacira BioSciences, Inc. (PCRX) reported raw materials of $39.81M in Q1 2026.

How has Pacira BioSciences, Inc.'s raw materials changed year-over-year?

Pacira BioSciences, Inc.'s raw materials decreased by 13.2% year-over-year, from $45.89M to $39.81M.

What is the long-term trend for Pacira BioSciences, Inc.'s raw materials?

Over 5 years (2020 to 2025), Pacira BioSciences, Inc.'s raw materials has grown at a 10.0% compound annual growth rate (CAGR), from $26.89M to $43.34M.

What does raw materials mean?

Unprocessed materials and components purchased for use in manufacturing, valued at cost.

Pacira BioSciences, Inc. PCRX Raw materials

Raw materials at other companies

Avanos MedicalAVNS

$34.1M-8.8%

Collegium Pharmaceutical, Inc.COLL

$20.05M—

AtriCureATRC

$39.09M+4.5%

Other financials

Income statement

See full

Revenue$177.4M+5.0%

Gross profit$141.0M+4.7%

Operating income$6.9M+247%

Net income$2.9M-39.4%

EPS (diluted)$0.07-30.0%

Balance sheet

See full

Cash & equivalents$144.3M-49.1%

Total debt$411.2M+15.3%

Total equity$653.9M-18.1%

Total assets$1.2B-23.8%

Cash flow

See full

Operating cash flow$25.7M-27.6%

CapEx$2.7M-68.1%

Free cash flow$23.0M-14.7%

Valuation

See full

Market cap$942.78M-16.0%

Enterprise value$1.21B+1.2%

P/E183.5×—

P/S1.3×-0.3×

Profitability

See full

Gross margin79.3%+1.7pp

Operating margin3.3%—

Net margin0.7%—

FCF margin18.1%-4.6pp

Returns & leverage

See full

Return on equity0.7%—

Debt / equity0.6×+0.2×

Current ratio4.7×+2.3×

Where this comes from

Reported directly by Pacira BioSciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InventoryRawMaterialsNetOfReserves.

The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacira BioSciences, Inc.'s raw materials.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Pacira BioSciences, Inc.'s raw materials?: Pacira BioSciences, Inc. (PCRX) reported raw materials of $39.81M in Q1 2026.
How has Pacira BioSciences, Inc.'s raw materials changed year-over-year?: Pacira BioSciences, Inc.'s raw materials decreased by 13.2% year-over-year, from $45.89M to $39.81M.
What is the long-term trend for Pacira BioSciences, Inc.'s raw materials?: Over 5 years (2020 to 2025), Pacira BioSciences, Inc.'s raw materials has grown at a 10.0% compound annual growth rate (CAGR), from $26.89M to $43.34M.
What does raw materials mean?: Unprocessed materials and components purchased for use in manufacturing, valued at cost.